• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

April 12, 2010: Blood Products Advisory Committee Meeting Agenda

AGENDA

BLOOD PRODUCTS ADVISORY COMMITTEE
National Institutes of Health
Building 29, Conference Room 121
9000 Rockville Pike, Bethesda, MD, 20892

Monday, April 12, 2010         

1:00 p.m. Opening Remarks, Blaine Hollinger, M.D., Acting Chair

Statement of Conflicts of Interest, Announcements

1:10 p.m. Topic I: Review of the Research Programs in the Laboratories of Cellular Hematology and Biochemistry and Vascular Biology

  1. Overview of CBER and OBRR Research, C.D. Atreya, Ph.D., Associate Director for Research, OBRR, FDA (20’)
  2. Overview of the Division of Hematology Research Program, Basil Golding, M.D., DH, OBRR, FDA (15’)
  3. Overview of the Laboratory of Cellular Hematology, Jaro Vostal, M.D., Ph.D., DH, OBRR, FDA (30’)
    Questions & Answers (15’)
  4. Overview of the Laboratory of Biochemistry and Vascular Biology, Abdu Alayash, Ph.D., DH, OBRR (30')
    Questions and Answers (15')

3:15 p.m. Open Public Hearing

4:15 p.m. Closed Committee Discussion

5:30 p.m. Adjournment